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ABSTRACT
Few studies have compared the long-term success of different surgical strategies in prosthetic knee-
associated infection. Accordingly, a retrospective cohort study was performed of 40 episodes in 35
consecutive patients undergoing revision surgery for prosthetic knee-associated infection at a single
centre between 1988 and 2003. The median patient age was 70 (44–90) years; the median follow-up
period was 28 (2–193) months; 45% of infections were early, 23% were delayed, and 32% were late; and
55% of infections were caused by staphylococci. The probability of survival without prosthesis failure
was 92.4% (95% CI, 84.1–100) after 1 year, and 88.7% (95% CI, 78–99.4) after 2 years. Recurrence-free
survival was observed in 20 (95%) of 21 patients treated with debridement and retention, in both
patients with one-stage exchange, and in 11 (85%) of 13 patients with two-stage exchange. Patients with
delayed infection had a worse outcome than those with early or late infection (67% vs. 97%; p < 0.03).
Patients with at least partially adequate antimicrobial therapy had a higher success rate than those with
inadequate treatment (94% vs. 60%; p 0.069). The outcome was similar for patients with a duration of
therapy of 3 to < 6 months, and those with a duration of therapy of ‡ 6 months (91% vs. 87% success).
Different surgical procedures had similar success rates, provided that the type of infection, the
pathogen, the stability of the implant and the local skin and soft-tissue condition were considered.
Adherence to an algorithm deﬁning a rational surgical and antibiotic treatment strategy contributed to a
favourable outcome.
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INTRODUCTION
Infection associated with total knee arthroplasty
(TKA) occurs in 0.5–2% of patients during the
ﬁrst 2 years following primary knee replacement
[1–4]. Treatment of such infections costs three-to-
four times more than the primary arthroplasty
itself [5]. Treatment options can be classiﬁed into
prosthesis retention, prosthesis exchange and
salvage procedures (arthrodesis or amputation).
The goal of therapy is eradication of infection,
resulting in a pain-free, functional joint. Antimi-
crobial suppression, arthrodesis or amputation
fulﬁl these requirements only partly. In contrast,
debridement with retention (combined with
appropriate antimicrobial therapy), one-stage ex-
change and two-stage exchange are the three
procedures which have the potential to achieve
the above goal [1,2]. Since controlled trials com-
paring these different surgical options are lacking,
and will probably never be performed, the choice
of the optimal treatment is still a matter of debate.
The morbidity and mortality associated with
repetitive surgery and anaesthesia are consider-
able. In addition, repetitive invasive procedures
may cause bone, muscle, soft-tissue and skin
defects, resulting frequently in impaired func-
tional integrity. Thus, the least invasive procedure
resulting in cure of infection is preferable. How-
ever, not only medical but also legal aspects may
play a role in choosing a speciﬁc surgical
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technique. Until now, the selection of surgical
intervention was driven mainly by the tradition at
individual institutions, and was not based on
well-deﬁned criteria. However, such criteria have
been published recently [2,6,7]. In many centres,
two-stage exchange is considered to be the pro-
cedure with the best chance of curing infection [8–
16]. Nevertheless, this procedure is costly, time-
consuming, and may result in increased damage
to bone, soft-tissue and skin. However, based
on case series and a single controlled study,
the intervention should be chosen according to
the type of infection (early, delayed or late), the
duration of infection, the stability of the implant,
the type of microorganism causing infection, and
the quality of the soft-tissue [17–19]. In patients
with prosthetic hip-associated infection, the out-
come was best if the patients were treated
according to a well-deﬁned algorithm [7]. In the
present retrospective cohort study, the character-
istics and outcome of TKA-associated infections
treated with different types of surgical and
antimicrobial approaches were evaluated.
PATIENTS AND METHODS
Setting, study site and patients
A retrospective cohort study was conducted of 40 consecu-
tive episodes in 35 patients undergoing surgery for TKA-
associated infection between November 1988 and December
2003. The Clinic of Orthopaedic Surgery is a 48-bed unit,
serving as a primary-care centre for orthopaedic surgery of
the extremities, and as a tertiary-care centre for revision
arthroplasty. During the 15-year study period, 534 patients
with primary knee arthroplasty were identiﬁed, among
whom 13 (2.4%) developed TKA-associated infection. In
addition, 22 patients were referred with TKA-associated
infection from other hospitals. All 35 patients (40 episodes)
were followed prospectively at regular intervals. Data
extracted from medical charts and electronic ﬁles included:
orthopaedic case history, type of infection, signs and
symptoms of infection, laboratory parameters of infection,
microbiology and histopathology results, imaging proce-
dures, and surgical and antimicrobial therapy.
Deﬁnition of infection
TKA-associated infection was diagnosed if a sinus tract
communicating with the joint space was present (documented
by arthrography or during surgery), or if at least two of the
following criteria were present: (1) at least one positive intra-
operative tissue or synovial ﬂuid culture; (2) ‡ 5 neutrophils
per high-power ﬁeld in peri-prosthetic tissue specimens; (3)
> 1700 leukocytes ⁄ lL and ⁄or > 65% neutrophils in synovial
ﬂuid [20]; (4) clinical and laboratory signs of infection; or (5)
radiological signs of infection. According to the time-interval
between implantation and clinical onset of infection, infections
were categorised into early (£ 3 months after surgery), delayed
(> 3–24 months after surgery) and late (‡ 24 months after
surgery) infection.
Outcome evaluation
‘Cure’ was deﬁned as an absence of clinical signs and
symptoms of infection, a C-reactive protein level of
< 10 mg ⁄L or an erythrocyte sedimentation rate of
< 20 mm ⁄h, and the absence of radiological signs of infection
at a follow-up visit ‡ 2 years after beginning antimicrobial
treatment. In the case of a second episode caused by
haematogenous seeding or by a new exogenous infection,
cure of the ﬁrst episode was deﬁned as the absence of the
original microorganism during revision for the second
episode. ‘Probable cure’ was deﬁned by the same criteria as
above, but with a follow-up period of < 2 years. A ‘new
infection’ was diagnosed if a new pathogen was identiﬁed
after initial cure, or if the infection involved a knee prosthesis
on the other side. ‘Deﬁnite failure’ was deﬁned as persistence
or recurrence of TKA-associated infection with the same or an
unknown pathogen during or after the completion of anti-
microbial therapy. ‘Probable failure’ was a possible persistence
or recurrence of TKA-associated infection that did not fulﬁl the
strict criteria for a TKA-associated infection. ‘Early death’ was
deﬁned as death within 28 days of the most recent surgical
intervention. ‘Death caused by sepsis’ was deﬁned as death
related to uncontrolled TKA-associated infection.
Appropriateness of treatment
The ﬁrst surgical intervention performed for each episode was
compared to a treatment algorithm published previously
[2,6,7] and was categorised as: (1) treatment according to the
algorithm, or more invasive therapy (e.g., two-stage instead of
one-stage exchange); or (2) less invasive therapy (e.g., retention
instead of prosthesis exchange). Similarly, antimicrobial treat-
ment was evaluated in comparison with published guidelines
[2] and classiﬁed as: (1) adequate therapy, deﬁned as an
antimicrobial agent given for a total duration of ‡ 6 months
with initial intravenous administration for ‡ 2 weeks
(‡ 6 weeks in patients undergoing two-stage exchange with
an 8-week interval if culture-negative at reimplantation), use of
appropriate drugs according to antimicrobial susceptibilities
and published clinical studies, use of drugs with efﬁcacy
against surface-adhering bacteria whenever possible [21–25]
and with good bioavailability; (2) partially adequate therapy,
deﬁned as use of an appropriate drug for 3 to < 6 months or
initial intravenous administration for £ 2 weeks; or (3) inade-
quate therapy, deﬁned as antimicrobial therapy that did not
correspond to either of the above categories.
Statistical analysis
For outcome analysis, categories were deﬁned as ‘success’
(cure or probable cure of the original infection) or ‘failure’
(deﬁnite or probable persistence or recurrence, early death
resulting from any cause, or death resulting from sepsis).
Categorical data were evaluated using a two-sided Fisher’s
exact test. The probability of survival and 95% CI without
failure were estimated using the Kaplan–Meier survival
method. If a new infection involved the prosthesis, the
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preceding episode was censored. Calculations were performed
using JMP v.5.1.2 (SAS Institute, Cary, NC, USA), with Origin
v.7.5 (OriginLab Corp., Northampton, MA, USA) used for
graphical analysis.
RESULTS
Demographic data
Table 1 summarises the characteristics of 40 epi-
sodes of TKA-associated infection in 35 patients.
No previous revision had been performed in 18
(45%) episodes; one revision preceded infection
in 12 (30%) episodes; and at least two revisions
preceded infection in ten (25%) episodes. Risk-
factors for prosthetic joint-associated infection
were diabetes mellitus (seven cases, 20%) and
rheumatoid arthritis (six cases, 17.1%). One
patient had simultaneous haematogenous seeding
in both prosthetic knees during sepsis caused by
Staphylococcus aureus. Four of the remaining 34
patients had a second episode of TKA-associated
infection involving the same prosthesis. In one
episode, the infection was considered to be a
recurrence; the other three episodes were new
infections. In one case, the second episode
occurred after arthrocentesis for a haemarthros
following knee distortion. In another case, the
second infection occurred after a penetrating
injury of the pre-patellar bursa by a plant thorn,
causing a S. aureus soft-tissue infection. The third
re-infection was caused by haematogenous seed-
ing during sepsis.
Clinical characteristics
Eighteen episodes were early infections (median
35, range 2–92 days). These infections were
acquired by the exogenous route, since no other
infectious focus with the same pathogen was
detected. Delayed infections were found in nine
episodes after a median of 311 days (range 113–
558 days). Thirteen episodes were late infections,
acquired predominantly via the haematogenous
route and manifesting after a median of 2908 days
(range 778–7777 days). Overall, in 16 (40%) epi-
sodes the clinical manifestation was acute, char-
acterised by a systemic inﬂammatory response
syndrome, including fever of > 38C in eight
(20%) episodes. Moderate pain (regular need for
analgesics during locomotion) or severe pain
(present at rest) was observed in 25 (62.5%)
episodes, local inﬂammation in 27 (67.5%) epi-
sodes, and sinus tract, abscess or wound dehis-
cence in ten (25%) episodes.
Microbiology
Table 2 summarises the spectrum of causative
microorganisms which were identiﬁed in 95% of
episodes. Two episodes comprised mixed infec-
tions, and no microorganism was cultured from
two episodes. Pathogens were identiﬁed by intra-
operative cultures (median, four positive tissue
specimens) in 27 (67.5%) episodes, and by syn-
ovial culture in ten (25%) episodes. One episode
(caused by S. aureus) was documented microbio-
logically only by a deep sinus tract culture.
Surgical and antimicrobial treatment
In 21 (52.5%) episodes, the prosthetic joint was
retained, and 20 patients had symptoms for
< 3 weeks. In ten cases, revision surgery, i.e.,
synovectomy, control of stability of the implant,
Table 1. Characteristics of 40 episodes of total knee
arthroplasty infection
Characteristics
Demographics
Median age (range), years 70.1 (43.5–90.1)
Male, n (%) 17 (48.6)
Median follow-up (range), months 28 (2–193)
Infection
First infection, n (%) 36 (90.0)
Re-infection, n (%) 4 (10.0)
Type of infection
Early (£ 3 months), n (%) 18 (45)
Delayed (> 3–24 months), n (%) 9 (22.5)
Late (> 24 months), n (%) 13 (32.5)
Type of acquisition of infection
Exogenous, n (%) 25 (62.5)
Haematogenous, n (%) 15 (37.5)
Table 2. Pathogens isolated from cases of total knee
arthroplasty infection
Microorganisma No. (%)
Staphylococcus aureusb 14 (33.3)
Coagulase-negative staphylococcic 9 (21.4)
Streptococcus spp. 5 (11.9)
Escherichia coli 3 (7.1)
Pseudomonas aeruginosa 2 (4.8)
Enterococcus faecalis 3 (7.1)
Peptostreptococcus spp. 1 (2.4)
Propionibacterium acnes 1 (2.4)
Hafnia alvei 1 (2.4)
Granulicatella adiacens 1 (2.4)
No growth 2 (4.8)
aTwo episodes were mixed infections, one with S. aureus plus Ent. faecalis, and one
with S. aureus plus coagulase-negative staphylococci.
bNone of the S. aureus isolates were methicillin-resistant.
cFive (55.6%) of nine isolates of coagulase-negative staphylococci were methicillin-
resistant.
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debridement and suction drainage, was per-
formed. Seven episodes were treated surgically
by arthroscopic lavage. In four episodes, earlypost-
operative superﬁcial wound debridement was
performedwithout re-opening the joint. One-stage
exchangewas chosen in only two (5%) episodes. In
13 (32.5%) episodes, two-stage exchange was the
initial treatment option. In each case of exchange
arthroplasty, debridement and suction drainage
was performed. A spacer was placed in ﬁve cases,
and external ﬁxationwas used to bridge the knee in
eight cases. The median interval from device
removal to reimplantation was 35 days (range 13–
116 days). Finally, three episodes were treated
with arthrodesis, and in one episode amputation
was required because of uncontrolled sepsis.
Table 3 summarises the details of the anti-
microbial therapy administered. Adequate, or
partially adequate, antimicrobial therapy was
administered in 35 (87.5%) episodes. Until 2002,
patients with quinolone- and rifampicin-suscept-
ible staphylococcal TKA-associated infection were
treated with ciproﬂoxacin plus rifampicin. There-
after, such patients were prescribed levoﬂoxacin
plus rifampicin, following initial intravenous treat-
ment with ﬂucloxacillin or vancomycin plus rif-
ampicin.
Outcome
The median duration of follow-up after the ﬁrst
surgical intervention was 28 months (range 2–
193 months). Fig. 1 shows the Kaplan–Meier esti-
mate of survival without failure. The probability of
survival without failure was 92.4% (95% CI, 84.1–
100) after 1 year, and 88.7% (95% CI, 78–99.4) after
2 years. Thirty-six of 40 episodes had a successful
outcome and required no additional surgical or
medical treatment during a median follow-up
period of 877 days (range 236–5879 days). Three
failures occurred during the ﬁrst year and one
during the second year (at day 624). In 27 (67.5%)
episodes followed for ‡ 2 years, there was a suc-
cess rate of 92.6% (25 of 27 episodes). Probable
success, i.e., no signs of infection, was observed
during a follow-up period of < 24 months in three
patients who died, in six patients who were
included during the year 2003, and in one patient
who was lost to follow-up. Seven (20%) of 35
patients died during the follow-up period.
Among the four episodes in patients with
treatment failure, three had a persistent infection
with the same pathogen. One patient died from
sepsis despite upper leg amputation, and another
received ciproﬂoxacin plus a placebo for S. aureus
infection, according to a treatment protocol of a
double-blind study published previously [17].
One patient acquired a new exogenous infection
during revision; this infection persisted despite a
further two-stage exchange of the prosthesis. The
two patients with delayed TKA-associated infec-
tion had clinical symptoms for a duration of
> 4 weeks. Table 3 shows the outcome according
to antimicrobial therapy. Those patients with a
treatment regimen that was at least partially
adequate had a cure rate of 94.3%, compared
with a rate of 60% (p 0.069) for the other patients.
Table 4 summarises the success rates according
to adherence to the algorithm, to type of infection,
Table 3. Outcome according to antimicrobial therapy
According to Success rate, no. (%)
Appropriateness of antimicrobial treatmenta
Adequate 26 ⁄ 28 (92.9)
Partially adequate 7 ⁄ 7 (100.0)
Inadequate 3 ⁄ 5 (60.0)b
Type of long-term oral treatment
Quinolone (ciproﬂoxacin or levoﬂoxacin)c 18 ⁄ 20 (90.0)
b-Lactam 7 ⁄ 7 (100.0)
Otherd 5 ⁄ 6 (83.3)
No long-term oral treatment 6 ⁄ 7 (85.7)
Combination therapy including rifampicin 22 ⁄ 23 (95.7)
Duration of antimicrobial therapye
Total treatment ‡ 6 months 20 ⁄ 23 (87.0)
Total treatment < 6 months 10 ⁄ 11 (90.9)
aFor deﬁnitions, see Patients and methods.
bAdequate ⁄partially adequate vs. inadequate: p 0.069.
cMostly in combination with rifampicin.
dFusidic acid, clindamycin, linezolid.
eSix episodes in patients with two-stage exchange without spacer were excluded
(see Patients and methods).
Fig. 1. Kaplan–Meier estimate of survival without failure
in 40 episodes of total knee arthroplasty-associated infec-
tion. The median follow-up in patients without failure was
838 days (range 236–5879 days).
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to pathogenesis, and to the different surgical
techniques used. The outcome did not differ
signiﬁcantly for patients treated according to the
algorithm, or for patients with different types of
pathogenesis (exogenous, haematogenous) or sur-
gery. In contrast, the success rate was signiﬁcantly
lower for patients with delayed infection than for
those with early or late infection (66.7% vs.
96.8%; p < 0.03). Retention had an overall success
rate of 95.2%, with a rate of 100% if the retention
was treated surgically with synovectomy (ten
episodes), or 90.9% with arthroscopic lavage. The
only patient with treatment failure received
inadequate long-term oral antimicrobial treat-
ment, namely ciproﬂoxacin alone against S. aureus
(see above).
The median follow-up period for six cases
treated with levoﬂoxacin plus rifampicin was
22 months (range 20–28 months). At the latest
follow-up visit, these patients had a probable
success rate of 100%. Five of these patients were
treated with debridement and retention, and one
patient was treated with two-stage exchange of
the prosthetic joint.
Functional result
After treatment, 52.8% of patients were mobile
without a crutch, 19.4% required one crutch,
13.9% required two crutches, and 8.3% needed a
wheelchair. One patient was not mobilised, and
information regarding the mobility of another
patient was missing. Three of the patients needed
an aid (crutch or wheelchair) for reasons other
than the functional result of the TKA, namely
Parkinson’s disease, amputation of the contralat-
eral leg following a trafﬁc accident, and cerebro-
vascular ischaemia.
DISCUSSION
The main ﬁnding from this study was the obser-
vation of a similar outcome for TKA-associated
infection following the application of different
surgical strategies deﬁned in a treatment algo-
rithm. Success rates after two-stage exchange,
one-stage exchange or debridement with retent-
ion were 85%, 100% (2 ⁄ 2) and 95%, respectively.
Results from case series and cohort studies are the
only resource for deﬁning the rational and opti-
mal treatment strategies for different types of
infection [2]. In the centre described in the present
study, all patients were followed prospectively at
regular intervals, and data were saved on elec-
tronic ﬁles [26].
Traditionally, two-stage exchange, combined
with treatment with intravenous antibiotics for
6 weeks, is the preferred regimen, especially in
the USA [8]. With this technique, the chance of
survival without recurrence is 89–100%
[9,11–16,27,28]. Retention with life-long antibiotic
suppression is an alternative for patients with
whom extensive surgery is considered to be too
great a risk [2]. Since the goal of treatment is the
elimination of infection while conserving the
functional integrity of the joint, the latter option
is not suitable, as it does not fulﬁl both require-
ments. Therefore, the outcomes associated with a
differential approach to different surgical strat-
egies, namely debridement with retention, one-
stage exchange and two-stage exchange, were
evaluated. These procedures were not chosen at
random, but according to criteria published pre-
viously [2,6,7]. The overall success rate of relapse-
free survival was 90%with a median follow-up of
28 months, and 92.6% if only patients with
follow-up for > 2 years were analysed. The micro-
organisms causing infection were comparable to
those reported in other studies, namely one-third
S. aureus, one-ﬁfth coagulase-negative staphylo-
cocci, and 12.5% streptococci [1,29].
One-stage exchange is performed rarely in
patients with TKA-associated infection. In the
present study, it was used in only two (5%) of the
episodes, and both cases had a favourable out-
come. This approach was used rarely because
most patients with prolonged symptoms had a
poor skin and soft-tissue quality; however a
Table 4. Outcome according to surgical therapy
Variable Success rate, no. (%)
Algorithm
Yes 24 ⁄ 26 (92.3)
No 12 ⁄ 14 (85.7)
Infection type
Early 18 ⁄ 18 (100.0)
Delayed 6 ⁄ 9 (66.7)a
Late 12 ⁄ 13 (92.3)
Pathogenesis
Haematogenous 15 ⁄ 15 (100.0)
Exogenous 21 ⁄ 25 (84.0)
Type of surgery
Debridement and retention 20 ⁄ 21 (95.2)
One-stage exchange 2 ⁄ 2
Two-stage exchange 11 ⁄ 13 (84.6)
Arthrodesis 3 ⁄ 3
Amputationb 0 ⁄ 1
aFisher’s exact test: p < 0.03 vs. early ⁄ late infection.
bEarly death caused by co-morbidity.
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German study reported a success rate of 73%
(76 ⁄ 104) with a follow-up of 5–15 years [30]. In a
Swedish study, 75.5% (81 ⁄ 107) of patients with
infected TKA were treated successfully, with no
difference between patients with one-stage or
two-stage procedures [3].
In contrast to most other studies, half of the
patients (21 ⁄ 40 episodes) in the present study
were treated with debridement and retention. This
procedure has been reported to have a high failure
rate with prosthetic joint infection, ranging from
40% to 83% in nine studies of patients with TKA-
associated infections [4,31–38]. Few studies have
reported a better outcome, but Mont et al. [39]
reported a failure rate of only 17% in 24 patients
with post-operative or late haematogenous infec-
tions. In the present study, the type of infection
had a crucial effect on the outcome. Whereas the
success rate was only 66.7% in patients with
delayed infection, it was 100% (18 ⁄ 18) in patients
with early infection, and 92.3% (12 ⁄ 13) in patients
with late haematogenous infection. Thus, as
reported previously, the short duration of infec-
tion in patients with early and haematogenous
infections is a prerequisite for a favourable out-
come if the device is not replaced [17,31].
Patients who received surgical treatment
according to a published algorithm had a slightly
better outcome than other patients (92.3% vs.
85.7%), although this difference did not reach
statistical signiﬁcance, probably because of the
small sample size. However, it is possible that the
choice of the surgical procedure is less important
in TKA than in hip prosthesis-associated infec-
tion, where a previous study found that the
difference was statistically signiﬁcant [7].
The type of antimicrobial therapy, and prob-
ably also the duration, plays an important role in
patients with device retention. Long-term therapy
with a rifampicin-containing combination in
patients with staphylococcal orthopaedic im-
plant-associated infection was 100% successful
in a controlled study, and was 86% successful in a
recent observational study [17,19]; however, only
a minority of patients in these studies had knee
prostheses. Rifampicin has a special efﬁcacy on
bioﬁlm-associated and stationary-phase staphylo-
cocci [21–25]. In the present study, 23 patients
treated with rifampicin-containing combinations
had a success rate of 95.7%, conﬁrming the good
results in previous studies with a larger series of
patients with total knee arthroplasty.
The duration of therapy has not been tested in
comparative studies, and is therefore still a matter
for debate [1,28]. In the present study, patients who
received therapy for 3 to < 6 months had an
outcome similar to that of patients who received
therapy for ‡ 6 months. Several previous studies of
patients with implant retention have advocated
use of antibiotics for several months [17–19], and in
view of the good results obtained in these, but not
in other studies [4,32–36], a treatment duration of
‡ 3 months seems rational. In a recent study, the
failure rate in 35 patients with two-stage exchange
and a 6-week course of antibiotics was 14% [40]. In
contrast, in three of 34 patients with persistently
positive cultures after therapy for 6 weeks, there
were no treatment failures after therapy for an
additional 6 weeks. Thus, even in patients with
two-stage exchange, antimicrobial therapy for
‡ 3 months is advisable if cultures are positive or
were not performed at the time of reimplantation.
In conclusion, debridement with retention of
the knee arthroplasty had a similar outcome to
two-stage exchange in patients with early and late
haematogenous infections with a short duration
of symptoms (< 3 weeks), a stable implant,
reasonable skin and soft-tissue quality, and
long-term antimicrobial therapy.
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